Good morning, everyone, and welcome to the IDEXX Laboratories' Third Quarter 2012 Earnings Conference Call. As a reminder, today's conference is being recorded.
Leadership changes and litigation risk should not scare investors away from financials, as quarterly results show that several names are currently a fairly good deal, says Morningstar's Jim Sinegal.
Some quirks boosted the September employment report, but several factors--including higher wages and a construction upturn--suggest tailwinds for further improvement ahead.
With double-digit increases looming for most Part D premiums, Morningstar columnist Mark Miller urges seniors to examine their options to ensure they are in the optimal drug plan for 2013.